Literature DB >> 20805012

Design and synthesis of bioactive adamantanaminoalcohols and adamantanamines.

Grigoris Zoidis1, Nicolas Kolocouris, John M Kelly, S Radhika Prathalingam, Lieve Naesens, Erik De Clercq.   

Abstract

Adamantanamines 16, 18, 21, 24, 27, 28, 30, 32, 35, 36, 37, 40, 46 and 48 were synthesized and tested for anti-influenza A virus and trypanocidal activity. The stereoelectronic requirements for optimal antiviral and trypanocidal potency were investigated. The effect of introducing a hydroxyl group close to the amino group on this class of compounds was examined for the first time. Aminoalcohol 24 proved to be the most active of the compounds tested against influenza A virus, being 6-fold more active than amantadine, equipotent to rimantadine and 26-fold more potent than ribavirin. Aminoalcohols 36 and 37 were found to have considerable activity against bloodstream forms of the African trypanosome, Trypanosoma brucei, being almost 10 times more potent than rimantadine.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20805012     DOI: 10.1016/j.ejmech.2010.08.009

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  9 in total

Review 1.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

2.  Exploring the Requirements for the Hydrophobic Scaffold and Polar Amine in inhibitors of M2 from Influenza A Virus.

Authors:  Jun Wang; Chunlong Ma; Victoria Balannik; Lawrence H Pinto; Robert A Lamb; William F Degrado
Journal:  ACS Med Chem Lett       Date:  2011-04-14       Impact factor: 4.345

3.  Synthesis of benzopolycyclic cage amines: NMDA receptor antagonist, trypanocidal and antiviral activities.

Authors:  Eva Torres; María D Duque; Marta López-Querol; Martin C Taylor; Lieve Naesens; Chunlong Ma; Lawrence H Pinto; Francesc X Sureda; John M Kelly; Santiago Vázquez
Journal:  Bioorg Med Chem       Date:  2011-12-02       Impact factor: 3.641

4.  Exploring synthetic and therapeutic prospects of new thiazoline derivatives as aldose reductase (ALR2) inhibitors.

Authors:  Muhammad Tariq Shehzad; Aqeel Imran; Abdul Hameed; Mariya Al Rashida; Marium Bibi; Maliha Uroos; Asnuzilawati Asari; Shafia Iftikhar; Habsah Mohamad; Muhammad Nawaz Tahir; Zahid Shafiq; Jamshed Iqbal
Journal:  RSC Adv       Date:  2021-05-11       Impact factor: 3.361

5.  Cholinesterase Inhibitory Activities of Adamantyl-Based Derivatives and Their Molecular Docking Studies.

Authors:  Huey Chong Kwong; Siau Hui Mah; Tze Shyang Chia; Ching Kheng Quah; Gin Keat Lim; C S Chidan Kumar
Journal:  Molecules       Date:  2017-06-17       Impact factor: 4.411

Review 6.  Emerging antiviral strategies to interfere with influenza virus entry.

Authors:  Evelien Vanderlinden; Lieve Naesens
Journal:  Med Res Rev       Date:  2013-06-25       Impact factor: 12.944

Review 7.  Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection.

Authors:  Suki Man-Yan Lee; Hui-Ling Yen
Journal:  Antiviral Res       Date:  2012-09-26       Impact factor: 5.970

8.  Crystal structure and Hirshfeld surface analysis of a pyridiniminium bromide salt: 1-[2-(adamantan-1-yl)-2-oxoeth-yl]pyridin-4-iminium bromide.

Authors:  Huey Chong Kwong; Imdad Mahmud Pathi; C S Chidan Kumar; Ching Kheng Quah; Md Azharul Arafath
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-06-28

9.  Synthesis and Crystallographic Insight into the Structural Aspects of Some Novel Adamantane-Based Ester Derivatives.

Authors:  C S Chidan Kumar; Huey Chong Kwong; Siau Hui Mah; Tze Shyang Chia; Wan-Sin Loh; Ching Kheng Quah; Gin Keat Lim; Siddegowda Chandraju; Hoong-Kun Fun
Journal:  Molecules       Date:  2015-10-16       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.